NCT06974422

Brief Summary

Aims: To evaluate the effectiveness of partial weight-bearing during aerobic exercise training on cardiovascular disease risk and peripheral vascular function in patients with type 2 diabetes mellitus. Study design: A Randomized controlled study was conducted in the outpatient rehabilitation unit. Population: Forty-six participants (age 60 -70) with type 2 diabetes mellitus were recruited and randomly allocated into three groups: group A (100% weight-bearing; n=16), group B (75% weight-bearing; n=16), and group C (control group; n=14). Methods: The 2 study groups A and B, received three sessions per week of moderate intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes session duration (including warm-up and cool-down), on the antigravity treadmill. The cardiovascular disease risk (evaluated using the Atherosclerotic cardiovascular disease risk estimator plus tool) and peripheral vascular function (presented by ankle-brachial pressure index, calculated by subdividing the ankle systolic blood pressure by the brachial systolic blood pressure) are the main study outcomes. Variables were evaluated pre-study and post-study. Ethical concepts and institutional regulations were adhered during the study. Data were described as mean and standard deviation. Paired samples t-test and one-way ANOVA were used to test within and between-subjects assumptions, respectively, considering p\< 0.05 as the significance level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

May 7, 2025

Last Update Submit

May 7, 2025

Conditions

Keywords

ExercisePartial Weight-BearingType 2 Diabetes MellitusCardiovascular DiseaseAnkle Brachial Index

Outcome Measures

Primary Outcomes (2)

  • Change in the cardiovascular disease risk at 12-week.

    The cardiovascular disease risk was evaluated using the Atherosclerotic cardiovascular disease risk estimator plus tool, and was evaluated pre-study and at 12 weeks (end of the study).

    From enrollment to the end of treatment at 12 weeks.

  • Change in the peripheral vascular function at 12-week.

    The peripheral vascular function (presented by ankle-brachial pressure index) was calculated by dividing the ankle systolic blood pressure by the brachial systolic blood pressure, and was evaluated pre-study and at 12 weeks (end of the study).

    From enrollment to the end of treatment at 12 weeks.

Study Arms (3)

Experimental Group-1 (group-A; 0% weight off-loading)

ACTIVE COMPARATOR

This group (100% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.

Behavioral: Full weight bearing during aerobic exercise training

Experimental Group-2 (group-B; 25% weight off-loading)

EXPERIMENTAL

This group (27% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.

Behavioral: Partial weight bearing during aerobic exercise training

Control group (Group; Non-exercising group)

OTHER

The control group participants received the same pre- and post-study evaluations as those for the study groups A and B, but did not participate in any aerobic exercise training on the antigravity treadmill. Participants only received regular oral anti-diabetic medications.

Drug: Regular oral anti-diabetic medications.

Interventions

Partial weight bearing (25% weight support) during the moderate intensity aerobic exercise training on the antigravity treadmill

Also known as: Antigravity treadmill aerobic exercise training, partial weight offloading during aerobic exercise training
Experimental Group-2 (group-B; 25% weight off-loading)

Full weight bearing (100% weight loading, 0% weight support) during moderate intensity aerobic exercise training on the antigravity treadmill.

Experimental Group-1 (group-A; 0% weight off-loading)

Participants in the control group (group C) received regular oral anti-diabetic medications.

Control group (Group; Non-exercising group)

Eligibility Criteria

Age60 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes mellitus patients with 0.6\< ankle brachial index ≤ 0.9, treated only with oral hypoglycemic medications (Biguanide or Sulfonylureas + Biguanide), oral anti-diabetic drugs combination, with stable pharmacological treatment for at least 3 months before the study.
  • Cognitively competent patients, able to walk independently with or without walking aids, assuming a Sedentary lifestyle (less than 30 minutes daily activity) during the last 6 months.
  • Type 2 diabetes mellitus for more than 10 years, with glycosylated hemoglobin (HbA1c% %) level more than 7%, and fasting glucose level more than 7.0 mmol/L.
  • Age range from 60 to 70 years, with normal/ accepted nutritional status (Mini Nutritional Assessment score more than 11).

You may not qualify if:

  • Patients with Type 1 diabetes, younger than 60 or older than 70 years.
  • Participation in any previous training program or diet regimen within the last 6 months.
  • Patients with disturbed nutritional status (Mini Nutritional Assessment score less than 11).
  • Serious musculoskeletal or cardiopulmonary disorders that can affect patient safety or the study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umm Al-Qura University

Mecca, Saudi Arabia

Location

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus, Type 2Motor Activity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Officials

  • ASHRAF AM ABDELAAL, Ph.D.

    Associate Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 15, 2025

Study Start

August 1, 2024

Primary Completion

March 1, 2025

Study Completion

May 1, 2025

Last Updated

May 15, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

For privacy reasons, data can not be exposed until results' publication. Data summary will be confidentially provided upon request under limited situations.

Locations